The Effect of Early versus Late Manipulation Under Anesthesia on Opioid Use, Surgical Complications, and Revision Following Total Knee Arthroplasty.
Journal
The journal of knee surgery
ISSN: 1938-2480
Titre abrégé: J Knee Surg
Pays: Germany
ID NLM: 101137599
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
medline:
3
8
2023
pubmed:
12
7
2022
entrez:
11
7
2022
Statut:
ppublish
Résumé
Previous studies of early versus late manipulation under anesthesia (MUA) do not report on postoperative opioid utilization or revisions and focused on small single-institution retrospective cohorts. The PearlDiver Research Program (www.pearldiverinc.com), which uses an all-inclusive insurance database, was used to identify patients undergoing primary total knee arthroplasty (TKA) who received (1) late MUA (>12 weeks), (2) early MUA (≤12 weeks), or (3) TKA only. To develop the control group cohort of TKA-only patients, 3:1 matching was conducted using 11 risk factor variables deemed significant by chi-squared analysis. Complications and opioid utilization were compared through multivariate regression analysis, controlling for age, gender, and Charlson Comorbidity Index. The risk of TKA revision was assessed through Cox-proportional hazards modeling and Kaplan-Meier survival analysis with log-rank test. Between 2011 and 2017, 2,062 TKA patients with early MUA, 1,112 TKA patients with late MUA, and a control cohort of 8,327 TKA-only patients were identified in the database. The percent of patients registering opioid use decreased from 54.6% 1 month pre-MUA to 4.6% (
Identifiants
pubmed: 35817059
doi: 10.1055/s-0042-1749607
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1132-1140Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
D.S.Y. reports personal fees from EOS, personal fees from Medicrea, personal fees from Medtronic Sofamor Danek, personal fees from Novabone, personal fees from Orthofix, Inc., personal fees from Southern Spine, personal fees from Spinneart, personal fees from Springer, personal fees from Stryker, outside the submitted work. The rest authors declare no conflict of interest.